Clinical Trial Update: An Evaluation of the Efficacy and Safety of FID 123472 Ophthalmic Solution for the Reduction of Ocular Redness [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of FID 123472 Ophthalmic Solution to reduce ocular redness in ocular hyperemia; the study is not yet r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hyperemia

Drugs mentioned

• FID 123472 Ophthalmic Solution

Snippet

Sponsor: Alcon Research | Conditions: Ocular Hyperemia | Phase 3 | Status: NOT_YET_RECRUITING